BNT162b2 is the clinical name of mRNA vax proteins. They use luciferase as a protein cognate to avoid direct implication but since it is a cognate, and pharmacokinetic effect such as liver absorption would, by definition, be considered a plausible concern with the real protein....
BNT162b2 is the clinical name of mRNA vax proteins. They use luciferase as a protein cognate to avoid direct implication but since it is a cognate, and pharmacokinetic effect such as liver absorption would, by definition, be considered a plausible concern with the real protein....